Kenneth Ain
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas (NCT00287287) | Kenneth Ain | 2006-02-01 |
| Thalidomide in Treating Patients With Thyroid Cancer (NCT00026533) | Kenneth Ain | 2001-06-01 |
Track Kenneth Ain automatically
Every clearance here is in the API, with alerts when new ones post.